About CSA Medical
Stopping Disease Cold
CSA Medical has advanced the proven science of cryotherapy. With the CryoSpray Ablation System, physicians have the ability to quickly and easily freeze, destroy and remove unwanted tissue, freeing patients from the discomfort and worry.
The CryoSpray Ablation system uses a patented technology to deliver liquid nitrogen through a catheter in a standard endoscope. This system of repetitive freeze-thaw cycles has been shown to destroy unwanted tissue, allowing new tissue to regenerate in its place.
Key Executives
Steven E. Schaefer, CPA
President and Chief Financial Officer
Click for bio.
Mr. Schaefer has over sixteen years of executive experience. Mr. Schaefer joined CSA Medical, Inc. full-time in 2006 as CFO and most recently was appointed President with a focus on expanding the growth of the GI business line. Previously, Mr. Schaefer was CEO of Schaefer & Associates, a Maryland-based consulting firm specializing in corporate advisory services for high growth companies where he began serving as a Board Member for CSA Medical. A Certified Public Accountant, he earned his degree in accounting and finance from Drexel University in Philadelphia.
Ron Burr, Ph.D.
Chief Technology Officer
Click for bio.
Dr. Burr joined CSA Medical, Inc. in 2008 as the Vice President of Product Development and now serves as the Company’s Chief Technology Officer. Prior to joining CSA Medical, he led cross-functional teams of R&D, marketing, operations, medical, regulatory, service, quality and finance personnel responsible for overall system design specification, implementation and validation of automated molecular diagnostic instruments for Becton Dickinson Diagnostic Systems. Dr. Burr earned his Ph.D. and MS in Mechanical Engineering from the University of Illinois and his BS in Mechanical Engineering from the University of Washington. A distinguished innovator, Dr. Burr currently holds 20 patents.
Richard Hughen
VP, Marketing & Business Development
Click for bio.
Mr. Hughen has over twenty years of professional experience in sales and marketing leadership, product management and strategic planning. He has successfully grown businesses in diverse environments including start up, mid-cap and fortune 100 companies. After spending five years with Johnson & Johnson and twelve years with Abbott Diagnostics, Mr. Hughen directed the marketing strategy and operations for the $120M molecular diagnostics business of Becton, Dickinson and Co. Mr. Hughen is a graduate of The Pennsylvania State University with an MBA in Marketing and BS in Environmental Science.
